The ISDS in the TTIP

Lieferzeit: Lieferbar innerhalb 14 Tagen

39,90 

Finding a balance between the right to regulate and investment protection

ISBN: 3659892734
ISBN 13: 9783659892738
Autor: Mascolo, Matteo
Verlag: LAP LAMBERT Academic Publishing
Umfang: 68 S.
Erscheinungsdatum: 25.06.2016
Auflage: 1/2016
Format: 0.5 x 22 x 15
Gewicht: 119 g
Produktform: Kartoniert
Einband: Kartoniert
Artikelnummer: 9573539 Kategorie:

Beschreibung

Among the aspects of the TTIP perceived as detrimental by public opinion, one seems to be considered the most controversial one: the inclusion of the Investor-State Dispute Settlement (ISDS) mechanism, upon which the European Commission decided to launch a public consultation. According to the respondents, ISDS represents a threat to the States right to regulate - especially in certain sensitive areas such as environmental protection, health, and labour. This is because it is assumed that governments, should they introduce public policy regulations affecting investments, could be exposed to costly claims by foreign companies, thus trigging the so-called regulatory chill effect. This study is split into two parts: the first part (chapter 2) analyses whether the fears about the ISDS clause are justified and if possible alternatives to this option exist. After having specified the legal meanings of regulatory chill and right to regulate, in the second part (chapter 3), this paper tackles the complex issue on how to find the balance between the two opposed interest of the parties in the TTIP: the right to regulate and investment protection.

Autorenporträt

Matteo is a junior advisor at Milieu Ltd. He holds a JD in Law and an LL.M in EU Law at the College of Europe. His main profession focus lies in the overlaps between law and policy. Specifically, he is studying the role that EU Law has in furthering policies of general interest and concern, such as trade, environment, energy and public health.

Herstellerkennzeichnung:


OmniScriptum SRL
Str. Armeneasca 28/1, office 1
2012 Chisinau
MD

E-Mail: info@omniscriptum.com

Das könnte Ihnen auch gefallen …